It is a chemicals private limited company based in Indore, Madhya Pradesh, India, established in 2021.
2021 | Indore, Madhya Pradesh, India | ActiveRazenta Pharmaceuticals Private Limited, a active private limited company, was established on 08 September 2021 in Indore, Madhya Pradesh, India. Engaging in fine chemicals and other chemical products within the chemicals sector, it holds CIN: U24299MP2021PTC057399. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Nirmal Gangwani (Additional Director), Yunus Ahamad (Additional Director), Pushpendra Kumar Tiwari (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 202 Amans Alid B. Block, 575 R Mahalaxmi Nagar, Indore, Madhya Pradesh, 452010.
U24299MP2021PTC057399
057399
08 September 2021
₹1.00 M
₹0.10 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Razenta Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nirmal Gangwani | Additional Director | 01 Mar 2022 | Current |
| Yunus Ahamad | Additional Director | 01 Nov 2021 | Current |
| Pushpendra Kumar Tiwari | Director | 08 Sep 2021 | Current |
| Rajesh Kumar Tiwari | Director | 08 Sep 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Razenta Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Razenta Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Razenta Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Razenta Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Razenta Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Razenta Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Razenta Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was recorded as a recent event.
Progress on Nirmal Gangwani was appointed as a Additional Director was appointed as a Additional Director on 01 Mar 2022 & has been associated with this company since 3 years 10 months . was documented.
Progress on Yunus Ahamad was appointed as a Additional Director was appointed as a Additional Director on 01 Nov 2021 & has been associated with this company since 4 years 2 months . was documented.
Pushpendra Kumar Tiwari was appointed as a Director was appointed as a Director on 08 Sep 2021 & has been associated with this company since 4 years 4 months . was recorded as a recent event.
Rajesh Kumar Tiwari was appointed as a Director was appointed as a Director on 08 Sep 2021 & has been associated with this company since 4 years 4 months . was recorded as a recent event.
The CIN of Razenta Pharmaceuticals Private Limited is U24299MP2021PTC057399.
Razenta Pharmaceuticals Private Limited is headquartered at 202 Amans Alid B. Block, 575 R Mahalaxmi Nagar, Indore, Madhya Pradesh, 452010.
Razenta Pharmaceuticals Private Limited was incorporated on 08 September 2021.
The current directors of Razenta Pharmaceuticals Private Limited are
The primary industry of Razenta Pharmaceuticals Private Limited is Chemicals.
Razenta Pharmaceuticals Private Limited is unlisted.
The authorized capital of Razenta Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX